Home/Filings/4/0001062993-21-004321
4//SEC Filing

STUART LEWIS J 4

Accession 0001062993-21-004321

CIK 0001042074other

Filed

May 9, 8:00 PM ET

Accepted

May 10, 5:55 PM ET

Size

5.4 KB

Accession

0001062993-21-004321

Insider Transaction Report

Form 4
Period: 2021-05-10
STUART LEWIS J
Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-05-10+360,000360,000 total
    Exercise: $3.94Exp: 2031-05-09Common Stock (360,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/4 of the underlying shares on May 10, 2022 and vests as to 1/48 of the underlying shares monthly thereafter.

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeother

Related Parties

1
  • filerCIK 0001407368

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 5:55 PM ET
Size
5.4 KB